Skip to main content
. Author manuscript; available in PMC: 2014 Jun 19.
Published in final edited form as: Mol Imaging Biol. 2013 Jul 9;16(1):85–94. doi: 10.1007/s11307-013-0665-4

Fig. 2.

Fig. 2

MIA PaCa-2 tumor vascularity correlated with tumor size. a MR contrast agent (i.e., gadoteridol) concentration in three representative mice bearing different-sized MIA PaCa-2 pancreatic tumors at t=0 (baseline), 5, and 20 min after injection. Tumor region is indicated with a black circle in each sub-figure. b Contrast-enhancement curves averaged in the ROIs indicated with white squares shown in Fig. 2a, while the time point of gadoteridol injection is indicated with a black arrow. c Mean Ktrans values versus mean tumor volumes. d Mean kep values versus mean tumor volumes. e Mean C20min values versus mean tumor volumes. f Mean C20min values versus mean Ktrans values.